A randomized controlled clinical trial to determine the optimum duration of G-CSF priming prior to BM stem cell harvesting

Cytotherapy

Volumn 9, Issue 2, 2007, Pages 158-164

  Lowenthal, R M ^a,b   Ragg, S J ^a   Anderson, J ^c   Nicholson, L ^a   Harrup, R A ^a   Tuck, D ^a  

^a ROYAL HOBART HOSPITAL   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c Tasmanian Support Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CD34 SELECTION; CELL CULTURE; CLINICAL TRIAL; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STUDENT T TEST; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BONE MARROW TRANSPLANTATION; CELL SEPARATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 34047185904     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240601182820     Document Type: Article

References (20)

1. Lowenthal, RM, Tuck, D. and Tegg, E. (1999) Hemopoietic stem cell harvesting and transplantation using G-CSF-primed bone marrow: comparison with unprimed bone marrow and G-CSF-primed PBSC. Cytotherapy, 1, pp. 409-416.
2. Hahn, U., Goldschmidt, H. and Salwender, H. (1995) Large-bore central venous catheters for the collection of peripheral blood stem cells. J Clin Apheresis, 10, pp. 12-16.
3. Sufliarska, S., Horakova, J. and Bodova, I. (2004) Allogeneic peripheral blood stem cell transplantations in children: A single center experience. Neoplasma, 51, pp. 110-116.
4. Tanimoto, TE, Yamaguchi, T. and Tanaka, Y. (2004) Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients. Br J Haematol, 125, pp. 480-493.
5. Sheridan, WP, Begley, CG and Juttner, CA (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, pp. 640-644.
6. + cells in healthy people. Transfus Med, 7, pp. 19-24.
7. + cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: An intraindividual crossover study. Transfusion, 44, pp. 104-110.
8. Dicke, KA, Hood, DL and Arneson, M. (1997) Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting. Exp Hematol, 25, pp. 34-38.
9. Damiani, D., Fanin, R. and Silvestri, F. (1997) Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood, 90, pp. 36-42.
10. Knudsen, LM, Hansen, SW and Daugard, G. (1998) Comparison of rhG-CSF primed bone marrow and blood stem cell autografts: An analysis of engraftment in malignant lymphomas and solid tumours. Eur J Haematol, 61, pp. 229-234.
11. Weisdorf, D., Miller, J. and Verfaillie, C. (1997) Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: A randomized comparison of GM-CSF vs. G-CSF. Biol Blood Marrow Transplant, 3, pp. 217-223.
12. Janssen, WE, Smilee, RC and Elfenbein, GJ. (1995) A prospective randomized trial comparing blood- and marrow-derived stem cells for hemopoietic replacement following high-dose chemotherapy. J Hematother, 4, pp. 139-140.
13. + cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry, 34, pp. 61-70.
14. Spurr, EE, Wiggins, NE and Marsden, KA (2002) Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage. Cryobiology, 44, pp. 210-217.
15. Tegg, EM, Tuck, DM, Lowenthal, RM and Marsden, KA. (1999) The effect of G-CSF on the composition of human bone marrow. Clin Lab Haematol, 21, pp. 265-270.
16. Lowenthal, RM, Fabéres, C. and Marit, G. (1998) Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: A retrospective analysis of a 10-year single institution experience. Bone Marrow Transplant, 22, pp. 763-770.
17. Price, TH, Chatta, GS and Dale, DC. (1996) Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood, 88, pp. 335-340.
18. Wall, DA. (2004) Allogeneic peripheral blood versus bone marrow transplantation: Children are small adults and more. J Clin Oncol, 22, pp. 4865-4866.
19. Eapen, M., Horowitz, MM and Klein, JP (2004) Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: The Histocompatibility and Alternative Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol, 22, pp. 4872-4880.
20. Cutler, C., Giri, S. and Jeyapalan, S. (2001) Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis. J Clin Oncol, 19, pp. 3685-3691.